Tech Company Financing Transactions
RayThera Funding Round
RayThera closed a $110 million Series A financing round on 4/7/2025. Investors included Foresite Capital and OrbiMed.
Transaction Overview
Company Name
Announced On
4/7/2025
Transaction Type
Venture Equity
Amount
$110,000,000
Round
Series A
Investors
Foresite Capital (Lead Investor)
OrbiMed (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance RayThera's lead drug candidates through Phase 1 clinical studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11988 El Camino Real 600
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Overview
World-class team of drug discovery and development experts with a proven track record of success. Founded in August 2023, RayThera is a small molecule drug discovery company with a mission to develop safer, more effective therapeutics to treat patients with immunological diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Qing Dong
Browse more venture capital transactions:
Prev: 4/7/2025: Different Dog venture capital transaction
Next: 4/7/2025: Miss Moneypenny Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs